Cancer Treatment Centers of America: Clinical Trials
Learn More About This Topic: Chat with Us | Email Us
A Randomized Phase II Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil(R)/Caelyx(R)In Combination Versus PLD Alone in Subjects with Platinum-Resistant Ovarian Cancer.
Summary
The purpose of this study is to test the effects of EC145 when used in combination with Doxil(R), as well as the safety of the combination of EC145 and Doxil(R) on platinum-resistant ovarian cancer .
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
